Möchten Sie immer auf dem neuesten Stand bleiben?

PharmAla expresses disappointment in USFDA's decision to request a third Phase 3 for MDMA and announces the patent granting for a safer MDMA analog variant

Dublin, Aug. 08, 2024 (GLOBE NEWSWIRE) -- The "Development of Domain Controllers in Centralized EEA Architecture" report has been added to ResearchAndMarkets.com's offering.This report provides an...

Dublin, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The "Architecture Services in Europe Market Size, Competitive Analysis and Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.The...

Dublin, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The "Architecture Services in Middle East and Africa Market Size, Competitive Analysis and Forecast to 2028" report has been added to ...

BOSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...

Completed enrollment of the planned 150 patients in COMPANION-002, a Phase 2/3 trial of CTX-009 plus paclitaxel versus paclitaxel in patients with previously treated, unresectable advanced Metastatic...

CAMP RIPLEY, Minn., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Today the Minnesota Military & Veterans Museum officially began construction on a 40,000-square-foot facility at Camp Ripley, Minn. This...

TORONTO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- KJA is thrilled to announce the promotion of Martin Ouimet, P. Eng., to the position of Chief Operating Officer (COO). This significant appointment marks a...

Chicago, July 18, 2024 (GLOBE NEWSWIRE) -- The Council on Tall Buildings and Urban Habitat (CTBUH) today announced the winner of its 2024 Lynn S. Beedle Lifetime Achievement Award: Santiago...

MOUNTAIN VIEW, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- HeartFlow, a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced it will be presenting new findings on...